AbbVie Inc. (ABBV) Social Stream



AbbVie Inc. (ABBV): $153.80

0.64 (+0.42%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

AbbVie Inc (ABBV) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering AbbVie Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-01 13 $140 $118 $128 $163.75 -21.83%
2021-11-23 12 $172 $118 $133.083 $163.75 -18.73%
2022-01-03 13 $172 $118 $135.538 $163.75 -17.23%
2022-01-05 13 $172 $118 $140.923 $163.75 -13.94%
2022-01-14 13 $172 $118 $143.416 $163.75 -12.42%
2022-01-19 13 $172 $118 $147.166 $163.75 -10.13%
2022-02-01 13 $172 $133 $149.916 $163.75 -8.45%
2022-02-03 13 $180 $133 $151.416 $163.75 -7.53%
2022-02-14 13 $180 $133 $153.5 $163.75 -6.26%
2022-02-17 13 $180 $133 $154.083 $163.75 -5.9%
2022-03-08 14 $180 $133 $153.538 $163.75 -6.24%
2022-03-16 14 $180 $133 $154.076 $163.75 -5.91%

The Trend in the Analyst Price Target


Over the past 56 days, ABBV's average price target has gone up $6.91.

Over the past 135 days, ABBV's average upside potential has been 7.19%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-23 12 172 118 133.083 118.88 11.95%
2021-12-09 13 172 118 135.538 124.15 9.17%
2022-02-17 13 180 133 154.083 144.97 6.29%
2022-02-28 14 180 133 153.538 147.77 3.9%
2022-03-08 14 180 133 153.538 147.15 4.34%

ABBV Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.64 9 1 4 0 0 14

The Trend in the Broker Recommendations


ABBV's average broker recommendation rating worsened by 0.06 over the prior 120 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ABBV as an investment opportunity.

  • In the context of all US stocks, AbbVie Inc's upside potential (average analyst target price relative to current price) is higher than 89.85% of them.
  • In the context of Pharmaceutical Products stocks, AbbVie Inc's average analyst price target is greater than 1530.25% of them.
  • AbbVie Inc's number of analysts covering the stock is higher than 1496.85% of Pharmaceutical Products stocks.
  • In the context of Pharmaceutical Products stocks, AbbVie Inc's variance in analysts' estimates is lower than -330.46% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to AbbVie Inc are TECH, SGEN, and RGEN.

Make investment decisions regarding ABBV using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.396 seconds.